Skip to main content
. 2020 Feb 1;21(3):970. doi: 10.3390/ijms21030970
ECM Extracellular matrix
HFpEF Heart failure with preserved ejection fraction
HG High glucose
α-SMA Alpha smooth muscle actin
ang II Angiotensin II
AT1 Angiotensin 1
ACE Angiotensin-converting enzyme
TGF-β Transforming growth factor beta
ERK Extracellular signal-regulated kinases
TSP1 Thrombospondin 1
Akt Protein kinase B
AMPK Activation of adenosine monophosphate-activated protein kinase
PI3 Phosphoinositide 3-kinase
EGF Epidermal growth factor
AGEs Advanced glycation end products
NF-κB Nuclear factor kappa B
RAGE Receptor for advanced glycation end products
IL Interleukin
O-GlcNAc O-GlcNAcylation
HMGB1 High-mobility group box 1
TLR4 Toll-like receptor 4
MMP Matrix metalloproteinase
TIMP Tissue inhibitor of metalloproteinase
miRNA MicroRNA
JNK c-Jun N-terminal kinase
MEF2 Myocyte enhancer factor 2
NO Nitric oxide
iNOS Inducible nitric oxide synthase
H2O2 Hydrogen peroxide
NOD1 Nucleotide oligomerization-binding domain 1
MeCP2 Methyl CpG-binding protein 2
RASSF1A Ras association domain family 1 isoform A
PAR-4 Protease activated receptor 4